Pfizer (United States)
In research, Pfizer (United States) stands highest in Medicine (#315 of 10,443 worldwide), Health Sciences (#494 of 11,982 worldwide) and Infectious Diseases (#15 of 345 worldwide), 2022–2025. Relative to its size it is most specialised in Statistics and Probability, Pharmacology and Pharmacology, Toxicology and Pharmaceutics — Statistics and Probability is 11.2× its share of world research.
- World rank, 2022–2025
- #882 of 28,054 · #635 all time
- Rank in United States
- #161 of 4,192
- Research works
- 19k ▼ 21% vs 2013–17
- Citations
- 791k 40.7 per fractional work
- Top-10% rate
- 23.8% record average 16.5%
- Open access
- 33% world 28%
What is Pfizer (United States) known for in research?
The fields where it stands highest, 2022–2025, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works | All time |
|---|---|---|---|---|---|
| MedicineField | #315 of 10,443 | 23.7% | 1,003 | #235 | |
| Health SciencesDomain | #494 of 11,982 | 23.4% | 1,058 | #299 | |
| Infectious DiseasesSubfield | #15 of 345 | 41.0% | 101 | #94 | |
| Life SciencesDomain | #415 of 7,800 | 26.5% | 531 | #272 | |
| Biochemistry, Genetics and Molecular BiologyField | #392 of 3,579 | 28.4% | 318 | #296 | |
| EpidemiologySubfield | #126 of 976 | 25.2% | 161 | #158 | |
| Molecular BiologySubfield | #330 of 2,175 | 29.5% | 198 | #238 | |
| Physical SciencesDomain | #2,083 of 12,888 | 23.5% | 312 | #1437 | |
| Organic ChemistrySubfield | #183 of 615 | 26.7% | 63 | #168 | |
| ChemistryField | #413 of 1,330 | 22.3% | 104 | #288 |
Each strip is that field’s whole ranked pool, with the notch where Pfizer (United States) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
Which of those standings moved
The same fields on both windows: where it stood over the whole record, and where it stands in 2022–2025. The distance is the story, and it is the one thing the two rank columns above cannot show.
- Medicine#235 #315
- Health Sciences#299 #494
- Infectious Diseases#94 #15
- Life Sciences#272 #415
- Biochemistry, Genetics and Molecular Biology#296 #392
- Epidemiology#158 #126
- Molecular Biology#238 #330
- Physical Sciences#1,437 #2,083
- Organic Chemistry#168 #183
- Chemistry#288 #413
A dot further right is a better standing. Fields it was not ranked in over the whole record are left out.
What does Pfizer (United States) specialise in?
Where its research is concentrated relative to its size: Statistics and Probability takes 11.2× the share of its output that it takes of world research.
- Statistics and ProbabilitySubfield · 48.9 works11×
- PharmacologySubfield · 33.2 works8.7×
- Pharmacology, Toxicology and PharmaceuticsField · 57.5 works8.0×
- HematologySubfield · 47.5 works7.7×
- Infectious DiseasesSubfield · 100.6 works7.2×
Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 8.0×. Every wedge is a field page.
- Pharmacology, Toxicology and Pharmaceutics 8.0×
- Immunology and Microbiology 5.6×
- Chemistry 3.2×
- Veterinary 3.2×
- Biochemistry, Genetics and Molecular Biology 2.9×
- Medicine 2.5×
- Mathematics 2.3×
- Economics, Econometrics and Finance 1.4×
- Health Professions 0.8×
- Decision Sciences 0.7×
- Neuroscience 0.5×
- Chemical Engineering 0.3×
- Computer Science 0.3×
- Psychology 0.3×
- Agricultural and Biological Sciences 0.2×
- Nursing 0.2×
- Materials Science 0.2×
- Environmental Science 0.2×
- Engineering 0.2×
- Social Sciences 0.2×
- Business, Management and Accounting 0.1×
- Dentistry 0.1×
- Energy 0.1×
- Physics and Astronomy 0.1×
- Arts and Humanities 0.0×
- Earth and Planetary Sciences 0.0×
Who are the top researchers at Pfizer (United States)?
Ranked on the composite score, Bradford D. Gessner, William C. Gruber and María Koehler lead among researchers whose main affiliation is Pfizer (United States).
- 1 Bradford D. Gessner · #7,660 worldwide 1.6k citations · 53 works
- 2 William C. Gruber · #25,697 worldwide 604 citations · 40 works
- 3 María Koehler · #40,286 worldwide 460 citations · 37 works
- 4 Ira Jacobs · #40,480 worldwide 298 citations · 51 works
- 5 Keith D. Wilner · #40,613 worldwide 481 citations · 33 works
- 6 Jennifer C. Moïsi · #63,610 worldwide 310 citations · 29 works
- 7 Max Kühn · #77,017 worldwide 1.3k citations · 24 works
- 8 Jon Bordner · #84,122 worldwide 187 citations · 41 works
- 9 Annaliesa S. Anderson · #87,529 worldwide 275 citations · 31 works
- 10 Xin Huang · #97,218 worldwide 263 citations · 24 works
Which keywords describe research at Pfizer (United States)?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Epidemiology, SARS-CoV-2, Pandemic, Monoclonal Antibodies, ACE2 Receptor, Vaccine, Vaccine Development and Clinical Trials.
- Bayesian Methods
- spike protein
- Pneumococcal Conjugate Vaccine
- Vaccination
- Respiratory Infections
- Therapeutic Antibodies
- Breast Cancer
- Coronavirus
- Medicinal Chemistry
- Immune Response
- Respiratory Syncytial Virus
- Pharmacokinetics
- Viral Infections
- Pathogenesis
- Cancer
- Vaccine Development
- Monoclonal Antibodies
- Biomarkers
- SARS-CoV-2
- Inflammation
- Epidemiology
- Pandemic
- Clinical Trials
- Vaccine
- ACE2 Receptor
- Clinical Practice Guidelines
- Immunity
- Immunotherapy
- Disease Burden
- Human Metapneumovirus
- Antimicrobial Resistance
- Chemotherapy
- Mutation
- Glycosylation
- Biopharmaceuticals
- Immunogenicity
- Viral Transmission
- Community-Acquired Pneumonia
- antibody
- Targeted Therapy
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Epidemiology294▲ 3.6×109 topics
- Inflammation100▲ 2.3×71 topics
- Pandemic91▲ 4.2×10 topics
- SARS-CoV-276▲ 11×6 topics
- Clinical Trials72▲ 5.2×17 topics
- Biomarkers66▲ 4.7×14 topics
- Vaccine64▲ 7.8×11 topics
- Monoclonal Antibodies64▲ 35×3 topics
- ACE2 Receptor64▲ 13×3 topics
- Vaccine Development63▲ 12×8 topics
- Clinical Practice Guidelines61▲ 5.4×14 topics
- Cancer60▲ 2.2×48 topics
- Immunity59▲ 7.1×11 topics
- Pathogenesis58▲ 5.5×20 topics
- Immunotherapy57▲ 3.9×19 topics
- Viral Infections57▲ 49×2 topics
- Disease Burden57▲ 38×2 topics
- Pharmacokinetics56▲ 10×9 topics
- Human Metapneumovirus56▲ 60×1 topic
- Respiratory Syncytial Virus56▲ 60×1 topic
- Antimicrobial Resistance55▲ 14×8 topics
- Immune Response55▲ 4.7×19 topics
- Chemotherapy54▲ 3.8×23 topics
- Medicinal Chemistry54▲ 9.4×11 topics
- Mutation49▲ 13×5 topics
- Coronavirus42▲ 9.7×3 topics
- Glycosylation42▲ 18×3 topics
- Breast Cancer41▲ 8.4×10 topics
- Biopharmaceuticals41▲ 39×3 topics
- Therapeutic Antibodies41▲ 29×2 topics
- Immunogenicity40▲ 45×3 topics
- Respiratory Infections39▲ 16×3 topics
- Viral Transmission39▲ 13×3 topics
- Vaccination38▲ 25×2 topics
- Community-Acquired Pneumonia38▲ 55×1 topic
- Pneumococcal Conjugate Vaccine38▲ 55×1 topic
- antibody38▲ 17×1 topic
- spike protein38▲ 17×1 topic
- Targeted Therapy37▲ 8.2×5 topics
- Bayesian Methods30▲ 30×2 topics
Which research topics does Pfizer (United States) publish most on?
By volume in 2022–2025: Respiratory viral infections research, Pneumonia and Respiratory Infections, SARS-CoV-2 and COVID-19 Research and Health Systems, Economic Evaluations, Quality of Life.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Respiratory viral infections researchEpidemiology 56 works
- 2 Pneumonia and Respiratory InfectionsEpidemiology 38 works
- 3 SARS-CoV-2 and COVID-19 ResearchInfectious Diseases 38 works
- 4 Health Systems, Economic Evaluations, Quality of LifeEconomics and Econometrics 29 works
- 5 Computational Drug Discovery MethodsComputational Theory and Mathematics 29 works
- 6 Statistical Methods in Clinical TrialsStatistics and Probability 26 works
- 7 Vaccine Coverage and HesitancyHealth 26 works
- 8 COVID-19 Clinical Research StudiesInfectious Diseases 26 works
- 9 Monoclonal and Polyclonal Antibodies ResearchRadiology, Nuclear Medicine and Imaging 25 works
- 10 Pharmacogenetics and Drug MetabolismPharmacology 25 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Pfizer (United States)'s research output changed?
Output in 2018–2022 was 21% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in New York
- Columbia University
- New York University
- Icahn School of Medicine at Mount Sinai
- Memorial Sloan Kettering Cancer Center
- City University of New York
- Human Growth Foundation
- Columbia University Irving Medical Center
- Rockefeller University
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.